<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Medical Device Courses | aysegultinas | Mentions</title>
	<link>https://medicaldevicecourses.com/members/aysegultinas/activity/mentions/</link>
	<atom:link href="https://medicaldevicecourses.com/members/aysegultinas/activity/mentions/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed mentioning aysegultinas.</description>
	<lastBuildDate>Sun, 15 Nov 2026 13:41:04 -0500</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">4b848ce6c48170e2235ead1313301c42</guid>
				<title>enzo.1216 replied to the topic  &#034;The Four Ps of Marketing for Medical Devices&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/59681/</link>
				<pubDate>Sun, 25 Oct 2026 23:18:07 -0400</pubDate>

									<content:encoded><![CDATA[<p><a href='https://medicaldevicecourses.com/members/aysegultinas/' rel="nofollow ugc">@aysegultinas</a> I like your point about total cost of ownership, because it changes how I think about price. I was picturing the number on the quote, but a hospital is really judging training time, maintenance, disposables, and whether insurers will&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/marketing-and-sales/the-four-ps-of-marketing-for-medical-devices/#post-24478" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">4fe758c63e4e745329256afd0e54a276</guid>
				<title>James Olson replied to the topic  &#034;The Secret Ingredient in Every Clinical Trial: Trust&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/59671/</link>
				<pubDate>Sun, 25 Oct 2026 22:08:54 -0400</pubDate>

									<content:encoded><![CDATA[<p><a href='https://medicaldevicecourses.com/members/aysegultinas/' rel="nofollow ugc">@aysegultinas</a> I agree that being upfront about the informed consent can greatly help build trust between the investigators and the subjects in the case of a blind study. I would like to further emphasize how useful everything disclosed in the&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/clinical-research-basics/the-secret-ingredient-in-every-clinical-trial-trust/#post-24470" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">6989c247aae82199688d61603241565e</guid>
				<title>dcapera replied to the topic  &#034;Should the corporate veil protect medical device executives?&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/58926/</link>
				<pubDate>Sun, 11 Oct 2026 05:39:49 -0400</pubDate>

									<content:encoded><![CDATA[<p><a href='https://medicaldevicecourses.com/members/aysegultinas/' rel="nofollow ugc">@aysegultinas</a>, I agree with your point that there should be a balance between protecting innovation and holding medical device companies accountable. I believe leaders in the medical device industry should have a higher level of responsibility because their decisions directly&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/business-101/should-the-corporate-veil-protect-medical-device-executives/#post-24316" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
		
	</channel>
</rss>